Home » Topics » BioWorld Science

BioWorld Science
RSS

Initiation of phase II study of ABI-H2158 in chronic hepatitis B

June 26, 2020

Precision model allows accurate cancer therapy testing

June 26, 2020

Sage Therapeutics synthesizes GABA-A receptor modulators

June 26, 2020

Byotrol patent describes antiviral phlorotannins

June 26, 2020

Novartis presents compounds for arthritis

June 26, 2020

Imperial College of Science, Technology and Medicine discloses MAP4K4 inhibitors

June 26, 2020

Merck & Co. divulges new hSTING agonists

June 26, 2020

FDA clears first clinical trial of M-5049 in patients with COVID-19 pneumonia

June 26, 2020

First patient dosed in phase II study of TD-0903 for the treatment of ALI caused by COVID-19

June 26, 2020

SCOHIA initiates phase II study of SCO-792 in diabetic kidney disease

June 26, 2020

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...